The Supreme Court sided with the FDA and unanimously ruled to uphold access to abortion pill mifepristone. The decision quells worries about what it might look like if the Supreme Court sided with the physician group — many healthcare leaders feared that if the top court could overturn mifepristone’s FDA approval, the same could happen to other drugs.

The post How Healthcare Leaders Are Reacting to the Supreme Court Preserving Abortion Pill Access appeared first on MedCity News.

Three upcoming Supreme Court decisions have the potential to radically change FDA regulation of medications.
The cases, which involve “Chevron deference” and the abortion pill mifepristone, were discussed on a panel during the BIO conference in San Diego.

The post Why a SCOTUS Ruling on Fishing Rules Could Change How FDA Regulates Drugs appeared first on MedCity News.

New York Governor Kathy Hochul signed new legislation that will protect the state’s doctors, medical providers and facilitators who prescribe abortion care telehealth services to patients outside of New York from litigation in states where abortion services are banned or restricted.

The post New York Signs Law To Protect State Providers Providing Abortion Drug Telemed Services to Out-of-State Patients appeared first on MedCity News.

If a drug’s FDA approval could be overturned by any judge, anywhere, anytime the pharmaceutical industry would be severely impacted. While mifepristone is no blockbuster, a legal precedent allowing courts to overturn the FDA’s approval could be applied to other drugs like blockbuster drugs like Viagra, Humira, or the new diabetes, weight-loss drugs Ozempic or Wegovy.

The post Courts Allowed to Ban Mife Today, Viagra Tomorrow? appeared first on MedCity News.

The current legal landscape makes access to medication abortion crucial in protecting as much access to reproductive healthcare as possible and in protecting healthcare providers’ abilities to do their jobs without fear of prosecution. 

The post Challenging State Abortion Bans in Light of FDA’s Rule Change on the Sale of Abortion Pills appeared first on MedCity News.

The group complains that the FDA never studied the safety of the drugs under the labeled conditions of use. 

The post Non-profit Sues FDA, Requesting the Agency Withdraw Approval for Abortion Drugs appeared first on MedCity News.